Lipid abnormalities in stable liver transplant recipients - Effects of cyclosporin, tacrolimus, and steroids

Transplant International

Volumn 11, Issue 2, 1998, Pages 137-142

  Fernández Miranda, Consuelo ^a   Guijarro, Carlos ^a,b   De La Calle, Angel ^a   Loinaz, Carmelo ^a   Gonzalez Pinto, Ignacio ^a   Gómez Izquierdo, Teresa ^a   Larumbe, Sagrario ^a   Moreno, Enrique ^a   Del Palacio, Angel ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b Instituto de Investigacion Hospital   (Spain)

Author keywords

Immunosuppression, liver transplantation, lipoproteins; Lipoproteins, liver transplantation, immunosuppression; Liver transplantation, lipoproteins, immunosuppression

Indexed keywords

CHOLESTEROL; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREDNISONE; STEROID; TACROLIMUS; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GRAFT REJECTION; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL;

ADULT; ANTI-INFLAMMATORY AGENTS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIPIDS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDNISONE; TACROLIMUS; TRIGLYCERIDES;

EID: 0031913365     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470050117     Document Type: Article

References (28)

1. Abouljoud MS, Levy MF, Klintmahn GB, and the US Multicenter Study Group (1995) Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US multicenter trial. Transplant Proc 27: 1121-1123
2. Andrews WSS, Shimaoka S, Sommerauer J, Moore P, Hudgins P (1994) Steroid withdrawal after pediatric liver transplantation. Transplant Proc 26: 159-160
3. Bumgardner GL, Wilson GA, Tso PL, Henry ML, Elkhammas EA, Davies EA, Qiu W, Ferguson RM (1995) Impact of serum lipids on long-term graft and patient survival after renal transplantation. Transplantation 60: 1418-1421
4. Castelao AM, Barberá MJ, Blanco A, Fiol C, Griño JM, Bover J, Gil-Vernet S, Andrés E, Serón D, Castiñeiras MJ, Alsina J (1992) Lipid metabolic abnormalities after renal transplantation under cyclosporine and prednisone immunosuppresssion. Transplant Proc 24: 96-98
5. Fontanals-Ferrer N, Serrat-Serrat J, Sorribas-Vivas A, Gonzalez-García C, Gonzalez-Sastre F, Gómez-Gerique J (1988) Quick method of determining lipoproteins, including those of intermediate density, in serum. Clin Chem 34: 1753-1757
6. Guckelberger O, Bechstein WO, Neuhaus R, Luesebrink R, Lemmens HP, Kratschmer B, Jonas S, Neuhaus P (1997) Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation. Clin Transplant 11: 60-65
7. Harris KPG, Russell GI, Parvin SD, Veitch PS, Walls J (1986) Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients. BMJ 292: 16
8. Ibels LLS, Alfrey AC, Weil R (1978) Hyperlipidemia in adult, pediatric and diabetic renal transplant recipients. Am J Med 164: 634-642
9. Imagawa DK, Dawson S III, Holt CD, Kirk PS, Kaldas FM, Shackleton CR, Seu P, Rudich SM, Kinkhabwala MM, Martin P, Goldtein LI, Murray NGB, Terasaki PI, Busuttil RW (1996) Hyperlipidemia after liver transplantation. Natural history and treatment with the hydroxy-methilglutaryl-coenzyme A reductase inhibitor pravastatin. Transplantation 62: 934-942
10. Isoniemi HM, Ahonen J, Tikkanen MJ, Willebrand EO, Krogerus L, Eklund BH, Höckerstedt KVA, Salmela KE, Häyry PJ (1993) Long-term consequences of different immunosuppressive regimens for renal allograft. Transplantation 55: 494-499
11. Jindal RM, Popescu I, Emre S, Schwartz ME, Boccagni P, Meneses P, Mor E, Sheiner P, Miller CM (1994) Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506. Transplantation 57: 1395-1398
12. Kasiske BL, Umen AJ (1987) Persistent hyperlipidemia in renal transplant patients. Medicine 66: 309-316
13. Krentz AJ, Cramb R, Dousset B, Mayer D, Mcmaster P, Buckels J, Smith JM, Nattrass M (1994) Serum lipids and apolipoproteins in liver transplant recipients: a comparative study of cyclosporin A and FK506. J Lab Clin Med 124: 381-385
14. Kuster GM, Drexel H, Bleisch JA, Rentsch K, Pei P, Binswanger U, Amann FW (1994) Relation of cyclosporine blood levels to adverse effects on lipoproteins. Transplantation 57: 1479-1483
15. Loss M, Winkler M, Schneider A, Brinkmann C, Manns M, Ringe B, Pichlmayr R (1995) Influence of longterm cyclosporine or FK506 therapy on glucose and lipid metabolism in stable liver graft recipients. Transplant Proc 27: 1136-1139
16. Malmendier CL, Lontie JF, Mathe D, Adam R, Bismuth H (1992) Lipid and apolipoprotein changes after orthotopic liver transplantation following end-stage liver diseases. Clin Chim Acta 209: 169-177
17. Mathe D, Adam R, Malmendier C, Gigou M, Lontie JF, Dubois D, Martin C, Bismuth H, Jacotot B (1992) Prevalence of dyslipemia in liver transplant recipients. Transplantation 54: 167-170
18. McDiarmid SV, Gornbein JA, Fortunat M, Saikali D, Vargas JH, Busuttil RW, Ament ME (1992) Serum lipid abnormalities in pediatric liver transplant patients. Transplantation 53: 109-115
19. McDiarmid SV, Farmer DA, Goldstein LI, Martin P, Vargas J, Tipton JR, Simmons F, Busuttil RW (1995) A randomized prospective trial of steroid withdrawal after liver transplantation. Transplantation 60: 1443-1450
20. Munoz SJ, Deems RO, Moritz MJ, Martin P, Jarrell BE, Maddrey WC (1991) Hyperlipidemia and obesity after orthotopic liver transplantation. Transplant Proc 23: 1480-1483
21. Palombo JD, Lopes SM, Zeisel SH, Jenkins RL, Albers JJ, Blackburn GL, Bistrian BR (1987) Effectiveness of orthotopic liver transplantation on the restoration of cholesterol metabolism in patients with end-stage liver disease. Gastroenterology 93: 1170-1177
22. Pirsch JD, Armbrust MJ, Knechtle SJ, Reed A, D'Alessandro AM, Sollinger HW, Beizer FO (1991) Effect of steroid withdrawal on hypertension and cholesterol levels in living related recipients. Transplant Proc 23: 1363-1364
23. Punch JD, Shieck VL, Campbell DA, Bromberg JS, Turcotte JG, Merion RM (1995) Corticosteroid withdrawal after liver transplantation Surgery: 118: 783-788
24. Raine AE, Carter R, Mann JI, Morris PJ (1988) Adverse effect of cyclosporine on plasma cholesterol in renal transplant recipients. Nephrol Dial Transplant 3: 458-463
25. Schulak JA, Hricik DE (1994) Steroid withdrawal after renal transplantation. Clin Transplant 8: 211-216
26. Steinmuller TM, Gràf KJ, Schleicher J, Leder K, Bechstein WO, Mueller AR, Dette K, Schulz E, Neuhaus P (1994) The effect of FK506 versus cyclosporine on glucose and lipid metabolism - a randomized trial. Transplantation 58: 669-674
27. Tchervenkov JI, Tector AJ, Cantarovich M, Tahta SA, Asfar A, Naimi J, Elias N, Barkun J (1996) Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients. Transplant Proc 28: 2247-2249
28. Vathsala A, Weinberg RB, Schoenberg L, Grevel J, Goldstein RA, Van Buren CT, Lewis RM, Kahan BD (1989) Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients. Transplantation 48: 37-43